How Irubis Built New Partnerships Across Asia's Biopharmaceutical Industry
Overview
Founded in Munich, Irubis develops advanced inline sensor technology that helps biopharmaceutical companies monitor and optimize bioprocesses in real time. Its innovative solutions improve efficiency, reduce costs, and support manufacturers in producing high-quality biologics with greater precision.
With customers across Europe and the United States, and distribution partners already established in China and Japan, Irubis saw South Korea as the next strategic step in completing its presence across Asia's rapidly growing biopharmaceutical market.
Why Irubis Chose German Accelerator
Although South Korea offered significant opportunities, entering the market required more than identifying potential customers.
The team needed to understand the country's distribution landscape, build relationships with trusted local partners, and learn how business decisions are made within Korea's biotechnology industry.
To support its expansion strategy, Irubis joined the German Accelerator Asia program. "The program helped us better understand how the Korean market works and gave us access to people we would not have been able to reach on our own."
How German Accelerator Helped Irubis
Throughout the program, Irubis worked closely with mentors and local experts to refine its market-entry strategy and better understand Korea's business environment. German Accelerator connected the company with experienced industry professionals who provided valuable insights into distribution channels, customer expectations, and partnership structures within the country's biopharmaceutical sector.
The mentorship also helped the team adapt its communication and sales approach to better align with Korean business culture. By tailoring presentations and focusing on the needs of local customers, Irubis strengthened its ability to engage potential partners and accelerate business development.
The program also reinforced the company's broader international strategy by encouraging a focused approach to expansion, prioritizing key markets before scaling further.
What Irubis Achieved After the Program
Following German Accelerator, Irubis strengthened its expansion strategy across Asia while advancing its presence in South Korea. The company established valuable relationships with potential distribution partners, gained a deeper understanding of the local biotechnology ecosystem, and refined its approach to customer engagement within the region.
Building on its existing presence in China and Japan, Irubis is now working toward completing its coverage of Asia's major biopharmaceutical markets while continuing preparations for further international growth, including expansion into the United States.
"Every market has its own way of doing business. Taking the time to understand local culture, build relationships, and identify the right partners creates a much stronger foundation for sustainable growth."
Advice for Other Startup Founders Considering International Expansion
For the Irubis team, successful international expansion is about understanding local markets before making long-term commitments.
The team also believes that staying focused is essential.
"Rather than expanding everywhere at once, concentrating on strategically important markets allows you to build stronger partnerships and create lasting impact."
Featured Case Studies
Do You Have Any Questions?
